{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:20:57Z","timestamp":1789546857825,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP21gm1410001"],"award-info":[{"award-number":["JP21gm1410001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["JP21H05734"],"award-info":[{"award-number":["JP21H05734"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["JP20H05784"],"award-info":[{"award-number":["JP20H05784"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15023"],"award-info":[{"award-number":["JP21K15023"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cbpa.2022.102158","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T07:01:39Z","timestamp":1652943699000},"page":"102158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Compounds for selective translational inhibition"],"prefix":"10.1016","volume":"69","author":[{"given":"Yuichi","family":"Shichino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-3754","authenticated-orcid":false,"given":"Shintaro","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2022.102158_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41580-018-0034-x","article-title":"Translation deregulation in human disease","volume":"19","author":"Tahmasebi","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2022.102158_bib3","doi-asserted-by":"crossref","first-page":"a033001","DOI":"10.1101\/cshperspect.a033001","article-title":"Translational control in virus-infected cells","volume":"11","author":"Stern-Ginossar","year":"2019","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-090817-062329","article-title":"Context-specific action of ribosomal antibiotics","volume":"72","author":"V\u00e1zquez-Laslop","year":"2018","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cbpa.2022.102158_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in\u00a0vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibs.2017.05.004","article-title":"The growing toolbox for protein synthesis studies","volume":"42","author":"Iwasaki","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cbpa.2022.102158_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aag1039","article-title":"PROTEIN TRANSLATION. Seeing translation","volume":"352","author":"Iwasaki","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib8","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1073\/pnas.1008685107","article-title":"Revisiting the structures of several antibiotics bound to the bacterial ribosome","volume":"107","author":"Bulkley","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib9","doi-asserted-by":"crossref","first-page":"17152","DOI":"10.1073\/pnas.1007988107","article-title":"Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action","volume":"107","author":"Dunkle","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib10","series-title":"Mechanism of action of antimicrobial and antitumor agents","first-page":"370","article-title":"Chloramphenicol","author":"Pestka","year":"1975"},{"key":"10.1016\/j.cbpa.2022.102158_bib11","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.1613055113","article-title":"Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center","volume":"113","author":"Marks","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42591","article-title":"A\u00a0systematically-revised ribosome profiling method for bacteria reveals pauses at single-codon resolution","volume":"8","author":"Mohammad","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.cbpa.2022.102158_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4065\/74.6.613","article-title":"The macrolides: erythromycin, clarithromycin, and azithromycin","volume":"74","author":"Alvarez-Elcoro","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cbpa.2022.102158_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib15","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/ncomms4501","article-title":"Molecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptide","volume":"5","author":"Arenz","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.molcel.2014.09.014","article-title":"Drug sensing by the ribosome induces translational arrest via active site perturbation","volume":"56","author":"Arenz","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib17","doi-asserted-by":"crossref","first-page":"12026","DOI":"10.1038\/ncomms12026","article-title":"A\u00a0combined cryo-EM and molecular dynamics approach reveals the mechanism of ErmBL-mediated translation arrest","volume":"7","author":"Arenz","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib18","doi-asserted-by":"crossref","first-page":"15379","DOI":"10.1073\/pnas.1410356111","article-title":"Sequence selectivity of macrolide-induced translational attenuation","volume":"111","author":"Davis","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib19","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1073\/pnas.1417334111","article-title":"The general mode of translation inhibition by macrolide antibiotics","volume":"111","author":"Kannan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib20","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.celrep.2016.07.018","article-title":"Binding of macrolide antibiotics leads to ribosomal selection against specific substrates based on their charge and size","volume":"16","author":"Sothiselvam","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2022.102158_sref21","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1038\/s41467-021-24674-9","article-title":"Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics","volume":"12","author":"Beckert","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1261\/rna.786408","article-title":"Mutation from guanine to adenine in 25S rRNA at the position equivalent to E.\u00a0coli A2058 does not confer erythromycin sensitivity in Sacchromyces cerevisae","volume":"14","author":"Bommakanti","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.cbpa.2022.102158_sref23","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","article-title":"Context-specific action of macrolide antibiotics on the eukaryotic ribosome","volume":"12","author":"Svetlov","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_sref24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41594-019-0236-8","article-title":"Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule","volume":"26","author":"Li","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001882","article-title":"Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain","volume":"15","author":"Lintner","year":"2017","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008057","article-title":"Cellular response to small molecules that selectively stall protein synthesis by the ribosome","volume":"15","author":"Liaud","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cbpa.2022.102158_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.chembiol.2016.08.016","article-title":"A\u00a0small-molecule anti-secretagogue of PCSK9 targets the 80S ribosome to inhibit PCSK9 protein translation","volume":"23","author":"Petersen","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis","volume":"62","author":"Urban","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cbpa.2022.102158_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cbpa.2022.102158_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cbpa.2022.102158_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cbpa.2022.102158_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","article-title":"PCSK9 inhibitors: clinical evidence and implementation","volume":"16","author":"Sabatine","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cbpa.2022.102158_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(02)00649-9","article-title":"The ribosomal exit tunnel functions as a discriminating gate","volume":"108","author":"Nakatogawa","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib34","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1261\/rna.029033.111","article-title":"Insights into the molecular determinants of EF-G catalyzed translocation","volume":"17","author":"Wang","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.cbpa.2022.102158_sref35","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/s41467-020-18765-2","article-title":"Selective inhibition of human translation termination by a drug-like compound","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0092-8674(04)00411-8","article-title":"The active site of the ribosome is composed of two layers of conserved nucleotides with distinct roles in peptide bond formation and peptide release","volume":"117","author":"Youngman","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib37","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1093\/nar\/gkx195","article-title":"Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain","volume":"45","author":"Koch","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2022.102158_bib38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41580-019-0118-2","article-title":"Mechanisms and functions of ribosome-associated protein quality control","volume":"20","author":"Joazeiro","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1192430","article-title":"Dom34:Hbs1 promotes subunit dissociation and peptidyl-tRNA drop-off to initiate no-go decay","volume":"330","author":"Shoemaker","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib40","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/emboj.2011.93","article-title":"Dissociation by Pelota, Hbs1 and ABCE1 of mammalian vacant 80S ribosomes and stalled elongation complexes","volume":"30","author":"Pisareva","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.cbpa.2022.102158_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.molcel.2012.03.013","article-title":"Dom34:hbs1 plays a general role in quality-control systems by dissociation of a stalled ribosome at the 3\u2032 end of aberrant mRNA","volume":"46","author":"Tsuboi","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41467-017-00188-1","article-title":"Ubiquitination of stalled ribosome triggers ribosome-associated quality control","volume":"8","author":"Matsuo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.molcel.2020.06.006","article-title":"The ASC-1 complex disassembles collided ribosomes","volume":"79","author":"Juszkiewicz","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib44","first-page":"2651","article-title":"Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model","volume":"118","author":"Bordeleau","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cbpa.2022.102158_bib45","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/cb400158t","article-title":"Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex","volume":"8","author":"Sadlish","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","article-title":"The scanning mechanism of eukaryotic translation initiation","volume":"83","author":"Hinnebusch","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cbpa.2022.102158_bib47","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.aba4904","article-title":"Structure of a human 48S translational initiation complex","volume":"369","author":"Brito Querido","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib48","doi-asserted-by":"crossref","first-page":"1238303","DOI":"10.1126\/science.1238303","article-title":"Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state","volume":"341","author":"Santagata","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib49","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1039\/c39820001150","article-title":"X-Ray crystal structure of rocaglamide, a novel antileulemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia","volume":"1","author":"King","year":"1982","journal-title":"J\u00a0Chem Soc Chem Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib50","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.chembiol.2019.08.008","article-title":"Amidino-rocaglates: a potent class of eIF4A inhibitors","volume":"26","author":"Chu","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102158_sref51","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.celrep.2020.02.002","article-title":"Rocaglates induce gain-of-function alterations to eIF4A and eIF4F","volume":"30","author":"Chu","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2022.102158_bib52","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","article-title":"Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor 4A RNA helicase","volume":"63","author":"Ernst","year":"2020","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cbpa.2022.102158_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0973","article-title":"Targeting oncogene mRNA translation in B-cell malignancies with eFT226, a potent and selective inhibitor of eIF4A","volume":"20","author":"Thompson","year":"2021","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.cbpa.2022.102158_bib54","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1182\/blood-2008-09-175430","article-title":"The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in\u00a0vitro and in\u00a0vivo","volume":"113","author":"Lucas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cbpa.2022.102158_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-8722-6-21","article-title":"Silvestrol exhibits significant in\u00a0vivo and in\u00a0vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia","volume":"6","author":"Alachkar","year":"2013","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.cbpa.2022.102158_bib56","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41375-021-01308-z","article-title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML","volume":"35","author":"Nishida","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.cbpa.2022.102158_bib57","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1007\/s00018-021-03910-x","article-title":"Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells","volume":"78","author":"Wilmore","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cbpa.2022.102158_bib58","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-019-13086-5","article-title":"eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma","volume":"10","author":"Chan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2022.102158_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/cells10020301","article-title":"Eukaryotic translation initiation factor 4AI: a potential novel target in neuroblastoma","volume":"10","author":"Skofler","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cbpa.2022.102158_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2668","article-title":"Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma","volume":"9","author":"Manier","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cbpa.2022.102158_bib61","doi-asserted-by":"crossref","first-page":"24409","DOI":"10.1038\/srep24409","article-title":"Fine-tuning of macrophage activation using synthetic rocaglate derivatives","volume":"6","author":"Bhattacharya","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2022.102158_bib62","doi-asserted-by":"crossref","first-page":"102845","DOI":"10.1016\/j.isci.2021.102845","article-title":"Channeling macrophage polarization by rocaglates increases macrophage resistance to Mycobacterium tuberculosis","volume":"24","author":"Chatterjee","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cbpa.2022.102158_bib63","doi-asserted-by":"crossref","first-page":"E2366","DOI":"10.1073\/pnas.1713000115","article-title":"Rocaglates as dual-targeting agents for experimental cerebral malaria","volume":"115","author":"Langlais","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib64","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1021\/jf990509h","article-title":"Cyclopenta[b]benzofurans from Aglaia species with pronounced antifungal activity against rice blast fungus (Pyricularia grisea)","volume":"48","author":"Engelmeier","year":"2000","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.cbpa.2022.102158_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03329-19","article-title":"Translation inhibition by rocaglates activates a species-specific cell death program in the emerging fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.cbpa.2022.102158_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/v10040149","article-title":"Inhibition of Zika virus replication by silvestrol","volume":"10","author":"Elgner","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cbpa.2022.102158_sref67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A\u00a0SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102158_bib68","doi-asserted-by":"crossref","first-page":"104706","DOI":"10.1016\/j.antiviral.2020.104706","article-title":"Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (\u2212) and the eIF4A-inhibitor Silvestrol","volume":"175","author":"M\u00fcller","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.cbpa.2022.102158_bib69","doi-asserted-by":"crossref","first-page":"105012","DOI":"10.1016\/j.antiviral.2021.105012","article-title":"The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in\u00a0vitro and ex\u00a0vivo","volume":"186","author":"M\u00fcller","year":"2021","journal-title":"Antivir Res"},{"key":"10.1016\/j.cbpa.2022.102158_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/rna.21966","article-title":"The DEAD-box helicase eIF4A: paradigm or the odd one out","volume":"10","author":"Andreou","year":"2013","journal-title":"RNA Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib71","doi-asserted-by":"crossref","first-page":"e5223","DOI":"10.1371\/journal.pone.0005223","article-title":"Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol","volume":"4","author":"Cencic","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2022.102158_bib72","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.1021\/jm3011542","article-title":"Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors","volume":"55","author":"Liu","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cbpa.2022.102158_bib73","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.celrep.2016.05.005","article-title":"CRISPR-mediated drug-target validation reveals selective pharmacological inhibition of the RNA helicase, eIF4A","volume":"15","author":"Chu","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2022.102158_bib74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13059-014-0476-1","article-title":"Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation","volume":"15","author":"Rubio","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102158_bib76","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature17978","article-title":"Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor","volume":"534","author":"Iwasaki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102158_sref77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.molcel.2018.11.026","article-title":"The translation inhibitor rocaglamide targets a bimolecular cavity between eIF4A and polypurine RNA","volume":"73","author":"Iwasaki","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib78","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41598-018-37666-5","article-title":"Oxo-aglaiastatin-mediated inhibition of translation initiation","volume":"9","author":"Itoua Ma\u00efga","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2022.102158_sref79","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chembiol.2020.11.008","article-title":"Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib80","first-page":"1134","article-title":"Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F","volume":"10","author":"Rozen","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cbpa.2022.102158_bib81","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1074\/jbc.274.18.12236","article-title":"Biochemical and kinetic characterization of the RNA helicase activity of eukaryotic initiation factor 4A","volume":"274","author":"Rogers","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cbpa.2022.102158_bib82","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.aaa5089","article-title":"RNA BIOCHEMISTRY. Factor-dependent processivity in human eIF4A DEAD-box helicase","volume":"348","author":"Garc\u00eda-Garc\u00eda","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2022.102158_bib83","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.87.21.8301","article-title":"Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes","volume":"87","author":"Kozak","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102158_bib84","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2011.05.005","article-title":"Translational control via protein-regulated upstream open reading frames","volume":"145","author":"Medenbach","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0258-0","article-title":"The helicase Ded1p controls use of near-cognate translation initiation codons in 5\u2032 UTRs","volume":"559","author":"Guenther","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102158_bib86","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.molcel.2018.03.015","article-title":"Polyamine control of translation elongation regulates start site selection on antizyme inhibitor mRNA via ribosome queuing","volume":"70","author":"Ivanov","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.cbpa.2022.102158_bib87","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gad.324715.119","article-title":"Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors","volume":"33","author":"Kearse","year":"2019","journal-title":"Genes Dev"},{"key":"10.1016\/j.cbpa.2022.102158_sref88","doi-asserted-by":"crossref","first-page":"109806","DOI":"10.1016\/j.celrep.2021.109806","article-title":"Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome","volume":"37","author":"Ho","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2022.102158_bib89","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1093\/nar\/gkab287","article-title":"DDX3 depletion represses translation of mRNAs with complex 5\u2032 UTRs","volume":"49","author":"Calviello","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2022.102158_bib90","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1208\/s12248-011-9276-7","article-title":"Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1\/P-glycoprotein overexpression in acute lymphoblastic leukemia cells","volume":"13","author":"Gupta","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.cbpa.2022.102158_bib91","doi-asserted-by":"crossref","first-page":"18516","DOI":"10.1038\/s41598-021-97765-8","article-title":"A\u00a0forward genetic screen identifies modifiers of rocaglate responsiveness","volume":"11","author":"Shen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2022.102158_sref92","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41589-020-0578-x","article-title":"Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel","volume":"16","author":"Osterman","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102158_fur1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41594-022-00720-y","article-title":"Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol.","volume":"29","author":"Syroegin","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.cbpa.2022.102158_fur2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41594-022-00723-9","article-title":"Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.","volume":"29","author":"Tsai","year":"2022","journal-title":"Nat Struct Mol Biol"}],"updated-by":[{"DOI":"10.1016\/j.cbpa.2024.102543","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:49:32Z","timestamp":1761274172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593122000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":94,"alternative-id":["S1367593122000436"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102158","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compounds for selective translational inhibition","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102158"}}